• Like
Pulmonary arterial hypertension global clinical trials review
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Pulmonary arterial hypertension global clinical trials review

  • 343 views
Published

GlobalData’s “Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2011” is now available at Marketreportsonline.com.

GlobalData’s “Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2011” is now available at Marketreportsonline.com.

Published in Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
343
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
2
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Pulmonary Arterial Hypertension Global ClinicalTrials Review, H2, 2011Published:October 2011No. of Pages:109Price: 1000Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2011SummaryGlobalDatas clinical trial report, “Pulmonary Arterial Hypertension Global Clinical Trials Review, H2,2011" provides data on the Pulmonary Arterial Hypertension clinical trial scenario. This report provideselemental information and data relating to the clinical trials on Pulmonary Arterial Hypertension. Itincludes an overview of the trial numbers and their recruitment status as per the site of trialconduction across the globe. The databook offers a preliminary coverage of disease clinical trials bytheir phase, trial status, prominence of the sponsors and also provides briefing pertaining to thenumber of trials for the key drugs for treating Pulmonary Arterial Hypertension. This report is builtusing data and information sourced from proprietary databases, primary and secondary research andin-house analysis by GlobalDatas team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevanceof data for the indicated disease.Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe,Middle-East and Africa and Asia-pacific and top five national contributions in each, along with theclinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsortype- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsortype and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
  • 2. Table of ContentsTable of Contents 2List of Tables 5List of Figures 7Introduction 8Pulmonary Arterial Hypertension 8Report Guidance 8Clinical Trials by Region 9Clinical Trials by Country 10Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12Top Five Countries Contributing to Clinical Trials in Europe 13Top Countries Contributing to Clinical Trials in North America 14Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15Top Five Countries Contributing to Clinical Trials in Central and South America 16Clinical Trials by BRIC Nations 17Clinical Trials by G7 Nations 18Clinical Trials in G7 Nations by Trial Status 19Clinical Trials by E7 Nations 20Clinical Trials in E7 Nations by Trial Status 21Clinical Trials by Phase 22In Progress Trials by Phase 23Clinical Trials by Trial Status 24Unaccomplished Trials of Pulmonary Arterial Hypertension 25Subjects Recruited Over a Period of Time 29Prominent Sponsors 30Top Companies Participating in Pulmonary Arterial Hypertension Therapeutics Clinical Trials 32Prominent Drug Comparison 34Clinical Trial Profiles 35Clinical Trial Overview of Top Companies 35Actelion Ltd 35Clinical Trial Overview of Actelion Ltd 35Pfizer Inc. 37Clinical Trial Overview of Pfizer Inc. 37United Therapeutics Corporation 39Clinical Trial Overview of United Therapeutics Corporation 39Bayer AG 41Clinical Trial Overview of Bayer AG 41Gilead Sciences, Inc. 42Clinical Trial Overview of Gilead Sciences, Inc. 42Novartis AG 43Clinical Trial Overview of Novartis AG 43GlaxoSmithKline plc 44
  • 3. Clinical Trial Overview of GlaxoSmithKline plc 44Lung Rx, Inc. 45Clinical Trial Overview of Lung Rx, Inc. (Subsidiary of United Therapeutics Corporation) 45Eli Lilly and Company 46Clinical Trial Overview of Eli Lilly and Company 46EPIX Pharmaceuticals, Inc. (Inactive) 47Clinical Trial Overview of EPIX Pharmaceuticals, Inc. (Inactive) 47Klinikum Wels - Grieskirchen GmbH 48Clinical Trial Overview of Klinikum Wels - Grieskirchen GmbH 48Aurora Health Care, Inc. 49Clinical Trial Overview of Aurora Health Care, Inc. 49ICOS Corporation 50Clinical Trial Overview of ICOS Corporation 50Global Health Ventures Inc. 51Clinical Trial Overview of Global Health Ventures Inc. 51Berlin Chemi AG 52Clinical Trial Overview of Berlin Chemi AG 52Medtronic Cardiac Rhythm Disease Management 53Clinical Trial Overview of Medtronic Cardiac Rhythm Disease Management 53Arena Pharmaceuticals, Inc. 54Clinical Trial Overview of Arena Pharmaceuticals, Inc. 54Aires Pharmaceuticals, Inc. 55Clinical Trial Overview of Aires Pharmaceuticals, Inc. 55Clinical Trial Overview of Encysive Pharmaceuticals Inc. 56Boehringer Ingelheim GmbH 57Clinical Trial Overview of Boehringer Ingelheim GmbH 57Clinical Trial Overview of Top Universities / Institutes / Hospitals 58Keio University 58Clinical Trial Overview of Keio University 58University of California, Los Angeles 59Clinical Trial Overview of University of California, Los Angeles 59Rabin Medical Center 60Clinical Trial Overview of Rabin Medical Center 60Assistance Publique - Hopitaux de Paris 61Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 61The Cleveland Clinic 62Clinical Trial Overview of The Cleveland Clinic 62University of Heidelberg 63Clinical Trial Overview of University of Heidelberg 63North Shore Long Island Jewish Health System 64Clinical Trial Overview of North Shore Long Island Jewish Health System 64Medical University of Vienna 65
  • 4. Clinical Trial Overview of Medical University of Vienna 65University of Cincinnati 66Clinical Trial Overview of University of Cincinnati 66Imperial College London 67Clinical Trial Overview of Imperial College London 67The University of Chicago 68Clinical Trial Overview of The University of Chicago 68Zhejiang University 69Clinical Trial Overview of Zhejiang University 69Mayo Clinic 70Clinical Trial Overview of Mayo Clinic 70Cardiovascular Institute & Fuwai Hospital 71Clinical Trial Overview of Cardiovascular Institute & Fuwai Hospital 71University of North Carolina Project 72Clinical Trial Overview of University of North Carolina Project 72Odense University Hospital 73Clinical Trial Overview of Odense University Hospital 73Nantes University Hospital 74Clinical Trial Overview of Nantes University Hospital 74Radboud University 75Clinical Trial Overview of Radboud University 75University of Alabama at Birmingham 76Clinical Trial Overview of University of Alabama at Birmingham 76UMC Utrecht 77Clinical Trial Overview of UMC Utrecht 77Five Key Clinical Profiles 78Appendix 106Source 110About Us:MarketReportsOnline is comprising of an online library of 50,000 reports, in-depth market researchstudies of over 5000 micro markets, and 25 industry specific websites. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market research reports.Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: + 1 888 391 5441E-mail: sales@marketreportsonline.comhttp://marketreportsonline.com/